aripiprazole has been researched along with quinpirole in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Bearden, M; Cui, J; Luedtke, RR; Mach, RH; Taylor, M; Vangveravong, S; Wang, W; Xu, J; Zhang, Z | 1 |
| Gmeiner, P; Hübner, H; Kling, RC; Leuner, K; Möller, D; Skultety, M | 1 |
| Gmeiner, P; Hübner, H; Kling, RC; Möller, D; Salama, I | 1 |
| Alzheimer, C; Banerjee, A; Bouvier, M; Friedland, K; Gmeiner, P; Hübner, H; Huth, T; Möller, D; Müller, CP; Plouffe, B; Skultety, M; Uzuneser, TC | 1 |
| Dengler, D; Gmeiner, P; Hübner, H; Männel, B; Möller, D; Shonberg, J | 1 |
| Gmeiner, P; Hübner, H; Männel, B; Möller, D | 1 |
| Cheng, J; Fan, L; Liu, R; Tan, L; Wang, H; Wang, S; Yan, W; Yu, J | 1 |
| Harano, M; Tanaka, M; Yamada, S; Yokoo, H | 1 |
| Inoue, A; Kikuchi, T; Miki, S; Misu, Y; Morita, S; Nakata, Y; Seto, M; Ueda, H | 1 |
| Mailman, RB; Urban, JD; Vargas, GA; von Zastrow, M | 1 |
| Hashioka, S; Horikawa, H; Iwaki, T; Kanba, S; Kato, T; Mizoguchi, Y; Monji, A; Seki, Y; Suzuki, SO | 1 |
| Abe, M; Egashira, N; Fujiwara, M; Iwasaki, K; Matsushita, M; Mishima, K; Nishimura, R; Oishi, R; Okuno, R | 1 |
| Charntikov, S; Crawford, CA; Der-Ghazarian, T; McDougall, SA; Varela, FA | 1 |
| De Carolis, L; Milella, MS; Nencini, P; Schepisi, C | 1 |
| Lowry, JP; O'Connor, JJ | 1 |
| Ma, GF; Ortiz, J; Raivio, N; Sabrià, J | 1 |
| Gao, J; Li, M; Qin, R | 1 |
| Bye, CR; Ganella, DE; Kim, JH; Lawrence, AJ; Madsen, HB; Perry, CJ; Zbukvic, IC | 1 |
18 other study(ies) available for aripiprazole and quinpirole
| Article | Year |
|---|---|
Synthesis and characterization of selective dopamine D₂ receptor ligands using aripiprazole as the lead compound.
Topics: Aripiprazole; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ligands; Piperazines; Protein Binding; Quinolones; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, sigma | 2011 |
Functionally selective dopamine D₂, D₃ receptor partial agonists.
Topics: Animals; Antipsychotic Agents; Arrestins; beta-Arrestin 2; beta-Arrestins; CHO Cells; Cricetulus; Drug Partial Agonism; GTP-Binding Protein alpha Subunits, Gi-Go; HEK293 Cells; Heterocyclic Compounds, 2-Ring; Humans; Mice; Molecular Docking Simulation; Oximes; Piperazines; Pyrazoles; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship; Swine | 2014 |
1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation.
Topics: Antipsychotic Agents; Binding Sites; HEK293 Cells; Humans; Ligands; Molecular Docking Simulation; Piperazines; Protein Structure, Tertiary; Quantitative Structure-Activity Relationship; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2 | 2015 |
Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure.
Topics: Animals; Antipsychotic Agents; beta-Arrestins; Dopamine Agonists; Drug Discovery; GTP-Binding Proteins; Humans; Male; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Schizophrenia | 2017 |
Hydroxy-Substituted Heteroarylpiperazines: Novel Scaffolds for β-Arrestin-Biased D
Topics: Animals; beta-Arrestins; CHO Cells; Cricetulus; Dopamine Agonists; Humans; Piperazines; Receptors, Dopamine D2 | 2017 |
β-Arrestin biased dopamine D2 receptor partial agonists: Synthesis and pharmacological evaluation.
Topics: Antiparkinson Agents; Antipsychotic Agents; beta-Arrestins; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Protein Binding; Receptors, Dopamine D2 | 2017 |
2-Phenylcyclopropylmethylamine Derivatives as Dopamine D
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Dopamine Agonists; Drug Design; Drug Evaluation, Preclinical; Half-Life; Humans; Mice; Mice, Inbred ICR; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship | 2021 |
Antagonistic effects of OPC-14597, a novel antipsychotic drug, on quinpirole- and (-)-sulpiride-induced changes in evoked dopamine release in rat striatal slices.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Dopamine; Dopamine Agents; Electric Stimulation; In Vitro Techniques; Male; Neostriatum; Piperazines; Quinolones; Quinpirole; Rats; Rats, Wistar; Sulpiride | 1997 |
Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Dopamine Agonists; GTP Phosphohydrolases; Haloperidol; Male; Membranes; Neostriatum; Oligonucleotides, Antisense; Piperazines; Quinolones; Quinpirole; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Up-Regulation | 1997 |
Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways.
Topics: Analysis of Variance; Animals; Arachidonic Acid; Aripiprazole; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Guanosine Triphosphate; Mitogen-Activated Protein Kinases; Piperazines; Quinolones; Quinpirole; Receptors, Dopamine D2; Signal Transduction | 2007 |
Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antipsychotic Agents; Aripiprazole; Brain; Calcium; Cell Survival; Cells, Cultured; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Interferon-gamma; Mice; Microglia; Neurons; Nitric Oxide; Piperazines; Quinolones; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Tumor Necrosis Factor-alpha | 2008 |
Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Anxiety; Aripiprazole; Behavior, Animal; Benzodiazepines; Catalepsy; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Indoles; Ketanserin; Male; Mice; Mice, Inbred ICR; Olanzapine; Piperazines; Piperidines; Postural Balance; Psychomotor Performance; Pyridines; Quinolones; Quinpirole; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Serotonin Antagonists; Serotonin Receptor Agonists | 2008 |
Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.
Topics: Aging; Animals; Animals, Newborn; Antipsychotic Agents; Aripiprazole; Autoreceptors; Brain Chemistry; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Drug Interactions; Female; Haloperidol; Male; Piperazines; Quinolones; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2010 |
Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Clomipramine; Compulsive Behavior; Conditioning, Operant; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drinking Behavior; Haloperidol; Male; Piperazines; Quinolones; Quinpirole; Rats; Rats, Sprague-Dawley | 2011 |
A comparison of the effects of the dopamine partial agonists aripiprazole and (-)-3-PPP with quinpirole on stimulated dopamine release in the rat striatum: Studies using fast cyclic voltammetry in vitro.
Topics: Animals; Aripiprazole; Corpus Striatum; Dopamine; Dopamine Agonists; Drug Partial Agonism; In Vitro Techniques; Male; Piperazines; Piperidines; Quinolones; Quinpirole; Rats; Rats, Wistar | 2012 |
Agonist and antagonist effects of aripiprazole on D₂-like receptors controlling rat brain dopamine synthesis depend on the dopaminergic tone.
Topics: Animals; Aripiprazole; Autoreceptors; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Piperidines; Potassium; Presynaptic Terminals; Quinpirole; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2014 |
Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Avoidance Learning; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Hyperkinesis; Male; Phencyclidine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2015 |
Role of Dopamine 2 Receptor in Impaired Drug-Cue Extinction in Adolescent Rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Cocaine; Cocaine-Related Disorders; Cues; Disease Models, Animal; Dopamine Agonists; Dopamine Uptake Inhibitors; Extinction, Psychological; Learning; Male; Motivation; Prefrontal Cortex; Quinpirole; Random Allocation; Rats, Sprague-Dawley; Receptors, Dopamine D2; Self Administration | 2016 |